Literature DB >> 17525627

The significance of Ki-67 proliferative index and cyclin D1 expression of dysplastic nevi in the biologic spectrum of melanocytic lesions.

Banu Lebe1, Uğur Pabuççuoğlu, Erdener Ozer.   

Abstract

Familial acquired dysplastic nevi carry a risk for the development of melanoma. However, the results in various studies regarding the significance of sporadic dysplastic nevi as a precursor of malignant melanoma (MM), are controversial. The aim of this study is to investigate cyclin D1 expression and Ki67 proliferative index in a group of melanocytic lesions to address the biologic significance of sporadic dysplastic nevi in the progression of melanocytic lesions. Formalin-fixed paraffin-embedded material from 21 common melanocytic nevi, 42 dysplastic nevi, and 17 primary cutaneous MMs were examined. Standard streptavidin-biotin immunoperoxidase method was used for immunostaining with cyclin D1 and Ki-67 antibody. Nuclear cyclin D1 immunostaining was scored and Ki-67 proliferative index was calculated. Cyclin D1 expression was significantly higher in melanoma than those in other lesions. However, there was no significant difference between dysplastic nevi and common melanocytic nevi in terms of cyclin D1 expression. Ki-67 index was significantly higher in dysplastic nevi compared with common melanocytic nevi and to melanoma compared with dysplastic nevi. There was a significant positive correlation between cyclin D1 expression and Ki-67 proliferative index for each group. The present study indicates significant differences in cyclin D1 expressions and Ki-67 indices among melanocytic lesions. We think that dysplastic nevi are biologically separate from common melanocytic nevi in terms of proliferative activity. Additionally, our results suggest that cyclin D1 expression may be related to malignant phenotype and is associated with high proliferation rate in MM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17525627     DOI: 10.1097/01.pai.0000209868.58699.64

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  9 in total

1.  A large-scale collection of giant congenital melanocytic nevi: Clinical and histopathological characteristics.

Authors:  Min Wu; Qingxiong Yu; Bowen Gao; Lingling Sheng; Qingfeng Li; Feng Xie
Journal:  Exp Ther Med       Date:  2019-11-14       Impact factor: 2.447

2.  The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management.

Authors:  Keith Duffy; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2012-07       Impact factor: 11.527

3.  Soluble adenylyl cyclase antibody profile as a diagnostic adjunct in the assessment of pigmented lesions.

Authors:  Cynthia M Magro; A Neil Crowson; Garrett Desman; Jonathan H Zippin
Journal:  Arch Dermatol       Date:  2011-11-21

4.  Protective effects of carvacrol and pomegranate against methotrexate-induced intestinal damage in rats.

Authors:  Gül Türkcü; Ulaş Alabalık; Ayşe Nur Keleş; Mehtap Bozkurt; İbrahim İbiloğlu; Uğur Fırat; Hüseyin Büyükbayram
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  Novel immune signatures associated with dysplastic naevi and primary cutaneous melanoma in human skin.

Authors:  Bernice Y Yan; Sandra Garcet; Nicholas Gulati; Felix Kiecker; Judilyn Fuentes-Duculan; Patricia Gilleaudeau; Mary Sullivan-Whalen; Avner Shemer; Hiroshi Mitsui; James G Krueger
Journal:  Exp Dermatol       Date:  2018-12-21       Impact factor: 3.960

6.  Protective Effect of Genistein on Cyclin D1 Expression in Malignant Ocular Melanoma Cells.

Authors:  Yasmin Sani Aprilliantina; Hera Dwi Novita; Elfina G Sadono; Rosy Aldina
Journal:  Med Arch       Date:  2021-06

Review 7.  Current and future trials of targeted therapies in cutaneous melanoma.

Authors:  Matthew S Evans; Subbarao V Madhunapantula; Gavin P Robertson; Joseph J Drabick
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

8.  The curcumin analog DM-1 induces apoptotic cell death in melanoma.

Authors:  Fernanda Faião-Flores; José Agustín Quincoces Suarez; Silvya Stuchi Maria-Engler; Vanessa Soto-Cerrato; Ricardo Pérez-Tomás; Durvanei Augusto Maria
Journal:  Tumour Biol       Date:  2013-01-29

Review 9.  From melanocytes to melanomas.

Authors:  A Hunter Shain; Boris C Bastian
Journal:  Nat Rev Cancer       Date:  2016-04-29       Impact factor: 60.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.